top of page
About HIP

ABOUT HIP


Originally established in 2009, HIP was founded to support medical device companies wanting to expand their reach into the Caribbean.

​

We have evolved to become the leading value-enhancement partner to our clients by providing a vast array of integrated services that bring strategic growth whilst increasing revenues and cash flow. We provide regulatory services to our client partners, all of which are market leaders in their fields.

OUR MISSION

​

HIP expedites medical companies to commercialize their products into Latin America, the Caribbean and select US markets.

​

We enable our client-partners to expand their market share via strategic regulatory and commercialization in an entrepreneurial and cost effective way.

​

​

​

​

​

OUR VISION

​

We partner with exceptional manufacturers and service providers in order to expand their reach into their target markets, primarily in the area of healthcare.

​

​

​

​

​

HOW WE ADD VALUE

​

We provide our client partners with the ability to control all their regulatory needs, and as a result, the commercialization of their products in each market.

REGULATORY
STRATEGY

Our goal is to assist our clients to comply with all government regulations aimed at protecting public health. Specifically, in the areas of pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, food and plants, dietary supplements, cosmetics and complementary medicines. With this, they can supply products that are safe and make a worthwhile contribution to public health and welfare.

STRATEGIC
COMMERCIALIZATION

At HIP, we make a difference within the healthcare spectrum by commercializing exceptional products into Latin America, The Caribbean and select US Markets.

Puzzle White Horizontal.png
HIP Focus Chart.png
  • Regulatory Strategy and Roadmap

​

  • Trademark Protection

​

  • Dossier Preparation and Submission

​

  • Regulatory Compliance

​

  • Liaison with Regulatory Agencies

​

  • Hosting on Behalf of Manufacturer

​

  • Representation with Regulatory Agencies

​

  • Regulatory Intelligence

​

  • Compliance Monitoring with Regulatory Agencies

​

  • Medical Device Vigilance Reporting (AE) / Technovigilance Reporting

​

  • Select USA and LATAM Markets

​

  • Pharmacovigilance and AE Reporting

​

  • Registration and Listing of Facilities/Establishments

​

  • Emergency Use Authorization (EUA) for Product Needs and in Different Countries with a Similar Process

Services + Capablities

SERVICES + CAPABILITIES

2750 SW 145 AVENUE, SUITE 101  |  MIRAMAR, FL 33027  |  305.351.9050

© HEALTHCARE INTERNATIONAL PARTNERS, LLC

bottom of page